The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 5 , Pages 1163-1170 , May 2007

Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model

  • Beat H. Walpoth, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
    • Corresponding Author InformationBeat H. Walpoth, MD, Clinic of Cardiovascular Surgery, University Hospital Geneva, 1211 Geneva 14, Switzerland
  • ,
  • Prisca Zammaretti, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Prisca Zammaretti and Mustafa Cikirikcioglu contributed equally to this article.
  • ,
  • Mustafa Cikirikcioglu, MD, PhD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
    • Prisca Zammaretti and Mustafa Cikirikcioglu contributed equally to this article.
  • ,
  • Ebrahim Khabiri, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • M. Karim Djebaili, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • Jean-Claude Pache, MD

      Affiliations

    • Department of Clinical Pathology, University of Geneva, Switzerland
  • ,
  • Jean-Christophe Tille, MD, PhD

      Affiliations

    • Department of Clinical Pathology, University of Geneva, Switzerland
  • ,
  • Yacine Aggoun, MD

      Affiliations

    • Department of Anaesthesiology Research, University of Geneva, Switzerland
  • ,
  • Denis Morel, MD

      Affiliations

    • Division of Pediatric Cardiology, University Hospital of Geneva, Switzerland
  • ,
  • Afksendiyos Kalangos, MD, PhD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • Jeffrey A. Hubbell, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Institute of Bioengineering, Swiss Federal Institute of Technology, Lausanne, Switzerland
  • ,
  • Andreas H. Zisch, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Department of Obstetrics, University Hospital of Zurich, Switzerland
    • Center for Integrative Human Physiology of the University of Zurich, Switzerland.
    • Corresponding Author InformationAddress for reprints: Andreas Zisch, PhD, Department of Obstetrics, University Hospital Zurich, Frauenklinikstr. 10, 8091 Zurich, Switzerland

Received 31 May 2006 ,Revised 24 August 2006 ,Accepted 19 September 2006.

References 

  1. Clowes AW. Improving the interface between biomaterials and the blood (The gene therapy approach). Circulation. 1996;93:1319–1320
  2. Walpoth BH, Rogulenko R, Tikhvinskaia E, Gogolewski S, Schaffner T, Hess OM, et al. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation. 1998;98:II319–II323discussion II324
  3. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg. 2001;71:S327–S331
  4. Kidd KR, Patula VB, Williams SK. Accelerated endothelialization of interpositional 1-mm vascular grafts. J Surg Res. 2003;113:234–242
  5. Greisler HP, Klosak JJ, Dennis JW, Karesh SM, Ellinger J, Kim DU. Biomaterial pretreatment with ECGF to augment endothelial cell proliferation. J Vasc Surg. 1987;5:393–399
  6. Greisler HP, Cziperle DJ, Kim DU, Garfield JD, Petsikas D, Murchan PM, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery. 1992;112:244–254discussion 254-5
  7. Wissink MJ, Beernink R, Poot AA, Engbers GH, Beugeling T, van Aken WG, et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release. 2000;64:103–114
  8. Hasson JE, Wiebe DH, Sharefkin JB, Abbott WM. Migration of adult human vascular endothelial cells: effect of extracellular matrix proteins. Surgery. 1986;100:384–391
  9. Bellon JM, Bujan J, Honduvilla NG, Hernando A, Navlet J. Endothelial cell seeding of polytetrafluoroethylene vascular prostheses coated with a fibroblastic matrix. Ann Vasc Surg. 1993;7:549–555
  10. Crombez M, Chevallier P, Gaudreault RC, Petitclerc E, Mantovani D, Laroche G. Improving arterial prosthesis neo-endothelialization: application of a proactive VEGF construct onto PTFE surfaces. Biomaterials. 2005;26:7402–7409
  11. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, Graziano P, et al. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res. 2005;127:70–79
  12. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release. 2001;72:101–113
  13. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release. 2005;101:93–109
  14. Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res. 2004;94:1124–1132
  15. Walpoth BH, Amonn A, Galdikas J, Ris HB, Schaffner T, Hoflin F, et al. Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment. Eur J Vasc Surg. 1993;7:493–499
  16. Bladin CF, Alexandrov AV, Murphy J, Maggisano R, Norris JW. Carotid Stenosis Index (A new method of measuring internal carotid artery stenosis). Stroke. 1995;26:230–234
  17. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91:2793–2801
  18. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation. 2004;110:2430–2435
  19. Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation. 2004;110:36–45
  20. Ohtani K, Egashira K, Hiasa K, Zhao Q, Kitamoto S, Ishibashi M, et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation. 2004;110:2444–2452
  21. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg. 1994;19:540–548
  22. Zarge JI, Husak V, Huang P, Greisler HP. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition. Am J Surg. 1997;174:188–192
  23. Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113:1596–1606
  24. Shiojima I, Walsh K. The role of vascular endothelial growth factor in restenosis: the controversy continues. Circulation. 2004;110:2283–2286
  25. Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188:359–368
  26. Grosskreutz CL, Anand-Apte B, Duplaa C, Quinn TP, Terman BI, Zetter B, et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res. 1999;58:128–136
  27. Khurana R, Zhuang Z, Bhardwaj S, Murakami M, De Muinck E, Yla-Herttuala S, et al. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation. 2004;110:2436–2443
  28. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783–790
  29. Rafii S, Heissig B, Hattori K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 2002;9:631–641

 The study was supported by grants of the Swiss National Science Foundation and the Swiss Heart Foundation to B. H. W., the Gebert Ruef Foundation to A. H. Z. and J. A. H., and the European Union FP6-project Heart Repair.

PII: S0022-5223(07)00217-6

doi: 10.1016/j.jtcvs.2007.01.029

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 5 , Pages 1163-1170 , May 2007